Merck Sharp & Dohme Corp. v. Sandoz Inc.

1:19-cv-00312

Overview

Case Number 1:19-cv-00312

Filing Date 2019-02-13

Status Litigation filed

Court District Court, D. Delaware (ded)

Nature of Suit 830 Patent

Cause of Action 35:271 Patent Infringement

Parties

Sandoz Inc.

0 Attorneys Listed

No attorneys available

Merck Sharp & Dohme Corp.

0 Attorneys Listed

No attorneys available

District Court, D. Delaware (ded)

Patents Involved

There is a single patent involved in this case.

Application Number	Patent Number	External Links
-	US7326708	Espacenet Google Patents

Docket Entries

Merck Sharp & Dohme Corp. v. Sandoz Inc.

Overview

Parties

Defendant

Sandoz Inc. Follow

Represented By

Plaintiff

Merck Sharp & Dohme Corp. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT for PATENT INFRINGEMENT filed against Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2569821.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmg) (Entered: 02/14/2019)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 02/14/2019)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/20/2010. Date of Expiration of Patent: 11/24/2026. (nmg) (Entered: 02/14/2019)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (nmg) (Entered: 02/14/2019)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (nmg) (Entered: 02/14/2019)

MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). (Entered: 02/21/2019)

DECLARATION of Mailing regarding service on Sandoz Inc. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). (Entered: 02/25/2019)

NOTICE of Appearance by Dominick T. Gattuso on behalf of Sandoz Inc. (Gattuso, Dominick) (Entered: 02/28/2019)

STIPULATION TO EXTEND TIME to ANSWER Complaint to April 10, 2019 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 02/28/2019)

ANSWER to 1 Complaint, Defenses, and COUNTERCLAIMS against All Plaintiffs by Sandoz Inc.. (Attachments: # 2 Certificate of Service)(Gattuso, Dominick) Modified on 4/10/2019 (nms). (Entered: 04/10/2019)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 04/10/2019)

MOTION for Pro Hac Vice Appearance of Attorney Keith A. Zullow, Emily L. Rapalino, Julius Jefferson, and Christie Larochelle - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 04/10/2019)

MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certification for Alexander S. Zolan)(Silver, Daniel) (Entered: 04/29/2019)

ANSWER to 10 Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 05/01/2019)

ORAL ORDER: The conference scheduled for 6/26/2019, at 10:00 am will now be held in Courtroom 2B. Ordered by Judge Richard G. Andrews on 6/19/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) (Entered: 06/19/2019)

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/24/2019 (nms). (Entered: 06/24/2019)

NOTICE of Appearance by Aaron M. Nelson on behalf of Sandoz Inc. (Nelson, Aaron) (Entered: 06/25/2019)

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/28/2019 (nms). (Entered: 06/28/2019)

NOTICE OF SERVICE of Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/02/2019)

STIPULATION TO EXTEND TIME Exchange of (i) Initial Disclosures pursuant to Rule 26(a); (ii) Paragraph 3 disclosures to July 26, 2019 - filed by Sandoz Inc., Teva Pharmaceutical Industries Ltd., Watson Laboratories, Inc.. (Gattuso, Dominick) (Entered: 07/08/2019)

STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 31, 2019 - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Mowery, Katharine) (Entered: 07/18/2019)

NOTICE OF SERVICE of Sandoz Inc.'s Intial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 07/26/2019)

NOTICE OF SERVICE of Plaintiff's Initial Dislcosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/26/2019)

STIPULATION TO EXTEND TIME Proposed Protective Order to August 7, 2019 - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) (Entered: 07/31/2019)

NOTICE OF SERVICE of Sandoz Inc.'s Core Technical Documents filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/01/2019)

STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to August 15, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/06/2019)

CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 8/8/2019 - Associated Cases: 1:19-md-02902-RGA et al.(amf) (Entered: 08/09/2019)

STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/15/2019)

PROPOSED Stipulated Protective Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms). (Entered: 08/19/2019)

SO ORDERED regarding Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) (Entered: 08/21/2019)

STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/27/2019 (nms). (Entered: 08/27/2019)

NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s First Sets of Interrogatories and First Sets of Requests for Production to Defendants filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 08/30/2019)

NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 09/13/2019)

NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-10) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 09/23/2019)

NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 10/01/2019)

NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 10/17/2019)

Track Case Updates

Sandoz Inc.

Merck Sharp & Dohme Corp.